This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab
Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomes
Arthritis Res 2002, 4(Suppl 2):S6-S10 doi:10.1186/ar553
Accesses
- Last 30 days: 46 accesses
- Last 365 days: 492 accesses
- All time: 6710 accesses

